The purpose of this study is to determine the safety of Nevanac 0.1% compared to Acular LS
0.4% and Vehicle in patients treated before cataract surgery and for approximately 90 days
following surgery.
Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery
Completed
Alcon Research
Phase 3
2005-09-01
The purpose of this study is to compare the effectiveness of Nepafenac Ophthalmic Suspension,
0.1% eye drops to Acular LS eye drops, used before and after cataract surgery, for treating
inflammation in the eye.
Effect of Prophylactic Ketorolac on CME After Cataract Surgery
Completed
Queen's University
N/A
2006-06-01
The study will evaluate the efficacy of prophylactic administration of the topical
nonsteroidal anti-inflammatory drug (NSAID) ketorolac tromethamine 0.5% (Acular®) on cystoid
macular edema (CME) in patients having undergone cataract surgery. CME is the most frequent
cause of decreased vision after uncomplicated cataract surgery and can result in irreversible
sight reduction. The investigation will involve a comparison arm and a treatment arm with
both sets of patient populations being evaluated for CME with ophthalmologic examinations and
optical coherence tomography (OCT) measurements. The objective is to elucidate the role of
NSAID drops in preventing CME after cataract surgery.
Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK
Completed
Allergan
Phase 4
2006-01-01
To determine the ability of two topical Nonsteroidal Anti-inflammatory drops (Acular LS &
Nevanac) to help control pain following Photorefractive Keratectomy (PRK).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
